Skip to main content

Levemir FDA Approval History

FDA Approved: Yes (First approved June 16, 2005)
Brand name: Levemir
Generic name: insulin detemir
Dosage form: Injection
Company: Novo Nordisk Inc.
Treatment for: Diabetes, Type 1, Diabetes, Type 2

Levemir (insulin detemir) is a novel, long- acting form of insulin that provides up to a 24-hour duration of action for the treatment of diabetes mellitus (type 1 and type 2).

Development timeline for Levemir

May 22, 2012Approval FDA Approves Levemir for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
Apr  2, 2012Approval FDA Approves Levemir Pregnancy Category Change for Women with Diabetes
Jun 16, 2005Approval Levemir Novo Nordisk Inc. - Treatment for Diabetes Mellitus (Type 1 and Type 2)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.